
Medullary Carcinoma, Thyroid (Mouse) courtesy of Dr. Alexander Yu Nikitin,
Medullary carcinoma of the thyroid gland of 485 days old Rb+/- female mouse. Courtesy of Dr. Alexander Nikitin, Cornell University. Remember that Rb LOH contributes to neuroendocrine tumorigenesis in knock out animals.
Click here to see the whole slide image.
Click here to view the human pathology.
References:
Randolph, GW and D Maniar. Medullary Carcinoma of the Thyroid. Cancer Control 2000, 7:253-261
Zhou Z, Flesken-Nikitin A, Levine CG, Shmidt EN, Eng JP, Nikitina EY, Spencer DM, Nikitin AY. Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice. Cancer Res. 2005 Feb 1;65(3):787-96. PubMed PMID: 15705875.
Matoso A, Zhou Z, Hayama R, Flesken-Nikitin A, Nikitin AY. Cell lineage-specific interactions between Men1 and Rb in neuroendocrine neoplasia. Carcinogenesis. 2008 Mar;29(3):620-8. Epub 2007 Sep 24. PubMed PMID: 17893233.
Related Posts
- Comparative Pathology: CNS Mass, December 12th, 2011
- Comparative Pathology: Mouse Models of Uterine Leiomyomas, November 28th, 2011
- Comparative Pathology: Pancreatic Mass, November 14th, 2011
- Comparative Pathology: Young Female with Breast Mass, October 31st, 2011
- Comparative Pathology: Li-Fraumeni Syndrome, October 17th, 2011
- Comparative Pathology: Hereditary Multiple Exostosis, October 3rd, 2011
- Comparative Pathology: Stomach Mass, September 19th, 2011
- Comparative Pathology: Elevated WBC Following Stress Event, August 8th, 2011
- Comparative Pathology: Mammary Gland Biopsy, August 22th, 2011
- Comparative Pathology: Carcinoid in the Lung, July 25th, 2011
Related posts:
- Slide of the Week: Medullary Thyroid Cancer, September 5th, 2011
- Comparative Pathology: Lung cancer, July 4th, 2011
- Comparative Pathology: Lobular Breast Cancer, March 9, 2011
- Comparative Pathology: Squamous Cell Carcinoma of the Lung, June 20th, 2011
- Comparative Pathology: Carcinoid in the Lung, July 25th, 2011
Comments
Powered by Facebook Comments